Phase 4 studies are best described as:

• A. Post marketing studies wherein data is sought from clinicians
• B. Delineates doctor satisfaction with outcomes of using the new treatment
• C. In the US there is evidence that phase 4 studies are not conducted with scientific rigour...
• D. They replace earlier phases

Answer: (A)

Phase 4 studies are post-marketing surveillance efforts aimed at monitoring safety and effectiveness after a drug has been approved and released. They gather real-world data from clinicians, patients, and other sources to detect rare or long-term adverse effects and to see how the therapy performs across broader, more diverse populations than those in earlier trials. This ongoing data collection helps manage risk, inform labeling or usage guidelines, and ensure the treatment remains safe and beneficial in routine practice. They are not about doctor satisfaction, they do not replace earlier trial phases, and while quality can vary, the defining feature is post-marketing data collection in real-world settings.